Unidade de Investigación en Cardioloxía Celular e Molecular
C.C.M.
![Foto de Unidade de Investigación en Cardioloxía Celular e Molecular](/img/grupo.png)
![Foto de Universidad de Cantabria](/img/noimage_org.png)
Universidad de Cantabria
Santander, EspañaPublicacións en colaboración con investigadores/as de Universidad de Cantabria (4)
2020
-
Reducing residual thrombotic risk in patients with peripheral artery disease: Impact of the COMPASS trial
Drugs in Context, Vol. 9
-
Residual risk reduction opportunities in patients with chronic coronary syndrome. Role of dual pathway inhibition
Expert Review of Clinical Pharmacology, Vol. 13, Núm. 7, pp. 695-706
2003
-
Infective endocarditis due to Streptococcus bovis in a series of nonaddict patients: Clinical and morphological characteristics of 20 cases and review of the literature
Canadian Journal of Cardiology, Vol. 19, Núm. 10, pp. 1139-1145
2001
-
Rheumatic manifestations of infective endocarditis in non-addicts: A 12-year study
Medicine, Vol. 80, Núm. 1, pp. 9-19